Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SONIC HEALTHCARE LIMITED

ABN

24 004 196 909

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Christopher David Wilks

Date of last notice

17 September 2019

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Direct and Indirect

Nature of indirect interest

Ordinary shares in Sonic Healthcare Limited are held in the name

(including registered holder)

of Hot Clothing Company Pty Ltd

Note: Provide details of the circumstances

giving rise to the relevant interest.

Ordinary shares in Sonic Healthcare Limited are held in the Sonic

Healthcare Employee Share Trust ("SHEST")

Date of change

17 September 2019, 18 September 2019 and 23 September 2019

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

No. of securities held prior to change

Direct

685,735 Sonic Healthcare Limited ordinary shares

101,633 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2015, expiring 20 November 2020; exercisable at $19.41 each under the Sonic Healthcare Limited Employee Option Plan having satisfied performance criteria

206,430 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2016 and will vest on 17 November 2019, subject to performance criteria over period 1 July 2016 to 30 June 2019; exercisable at $21.62 each under the Sonic Healthcare Limited Employee Option Plan

27,021 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2016 and will vest on 17 November 2019, subject to performance criteria over period 1 July 2016 to 30 June 2019, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan

207,678 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020; exercisable at $21.64 each under the Sonic Healthcare Limited Employee Option Plan

26,996 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan

205,415 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021; exercisable at $21.69 each under the Sonic Healthcare Limited Employee Option Plan

26,934 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan

Indirect

73,000 Sonic Healthcare Limited ordinary shares held by Hot Clothing Company Pty Ltd

12,190 Sonic Healthcare Limited ordinary shares held by CPU Share Plans Pty Limited atf SHEST

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Class

Fully paid ordinary shares in Sonic Healthcare Limited

Number acquired

Nil

Number disposed

Forfeited:

133,323 unlisted options over ordinary shares in Sonic

Healthcare Limited with an exercise price of $21.62 each

under the Sonic Healthcare Limited Employee Option Plan;

and

17,451 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited with Nil exercise price under the

Sonic Healthcare Limited Performance Rights Plan

as a result of not meeting the long-term incentive performance

conditions over the measurement period from 1 July 2016 to 30

June 2019.

Sold 120,000 ordinary shares in Sonic Healthcare Limited

to fund the recent exercise of options.

Value/Consideration

$27.932 per share on the sale of ordinary shares.

Note: If consideration is non‐cash, provide

details and estimated valuation

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3

Appendix 3Y

Change of Director's Interest Notice

No. of securities held after change

Direct

565,735 Sonic Healthcare Limited ordinary shares

101,633 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2015, expiring 20 November 2020; exercisable at $19.41 each under the Sonic Healthcare Limited Employee Option Plan having satisfied performance criteria

73,107 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2016, expiring 17 November 2021; exercisable at $21.62 each under the Sonic Healthcare Limited Employee Option Plan, which will vest in November 2019, having satisfied performance criteria

9,570 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2016 which will vest in November 2019 having satisfied performance criteria with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan

207,678 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020; exercisable at $21.64 each under the Sonic Healthcare Limited Employee Option Plan

26,996 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2017 and will vest on 22 November 2020, subject to performance criteria over period 1 July 2017 to 30 June 2020, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan

205,415 unlisted options over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021; exercisable at $21.69 each under the Sonic Healthcare Limited Employee Option Plan

26,934 unlisted performance rights over ordinary shares in Sonic Healthcare Limited, issued in 2018 and will vest on 21 November 2021, subject to performance criteria over period 1 July 2018 to 30 June 2021, with Nil exercise price under the Sonic Healthcare Limited Performance Rights Plan

Indirect

73,000 Sonic Healthcare Limited ordinary shares held by Hot Clothing Company Pty Ltd

12,190 Sonic Healthcare Limited ordinary shares held by CPU Share Plans Pty Limited atf SHEST

Nature of change

Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back

  • On 17 September 2019 and 18 September 2019, on-market sale of shares (120,000 shares in total) to fund the recent exercise of options.
  • 133,323 options and 17,451 rights forfeited on 23 September 2019 in accordance with the terms of the options and performance rights grants.

+ See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non‐cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Sonic Healthcare Limited published this content on 23 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2019 06:56:02 UTC